# Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders

> **NCT04761770** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 33 (actual)

## Conditions studied

- Myelodysplastic Syndrome
- Myeloproliferative Neoplasms
- Chronic Myelomonocytic Leukemia
- Atypical Chronic Myeloid Leukemia
- Myelodysplastic/Myeloproliferative Overlapping Syndrome

## Interventions

- **OTHER:** Geriatric assessment (GA) pre-transplant
- **DRUG:** conditioning regimen
- **PROCEDURE:** Allogeneic CD34+ selected stem cells

## Key facts

- **NCT ID:** NCT04761770
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-02-15
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04761770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04761770, "Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04761770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*